Dysplastic nevus
https://en.wikipedia.org/wiki/Dysplastic_nevus
☆ AI Dermatology — Free ServiceI le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi. 

Dysplastic nevi ― E fautuaina le biopsy mo tagata papalagi.

O le nevu le masani (dysplastic nevus) o se siepi lea e ese le foliga mai le nevu masani. E masani ona tupu tele le nevu le masani nai lo le nevu masani ma e mafai ona iai pā'ū le le masani, le le manino. E manaʻomia se biopsi mo le fa'amaonia.

Fa'aletonu foliga e fetaui ma ta'iala o le ABCD tulafono (asymmetry), ae o le fa'ai'uga e ono fesuisuia'i i le va o tagata su'esu'e.
relevance score : -100.0%
References
Dysplastic Nevi 29489189 NIH
Dysplastic nevus, ua lauiloa foi o se atypical mole, poʻo Clark's nevus, ua faʻaoso felanolafoaiga i dermatology ma dermatopathology. E masani ona su'esu'e e foma'i nei mole ona e foliga mai e le masani ma fa'atupu ai popolega e uiga i le melanoma.
A dysplastic nevus is also referred to as an atypical or Clarks nevus and has been the topic of much debate in the fields of dermatology and dermatopathology. It is an acquired mole demonstrating a unique clinical and histopathologic appearance that sets it apart from the common nevus. These moles appear atypical clinically, often with a fried-egg appearance, and are commonly biopsied by providers due to the concern for melanoma.
Publication Trends and Hot Topics in Dysplastic Nevus Research: A 30-Year Bibliometric Analysis 37992349 NIH
Dysplastic nevi, e taʻua foʻi o le atypical poʻo Clark nevus, e mafai i nisi taimi ona oʻo atu i le melanoma. E tusa ma le 36 % o melanomas e maua i tafatafa o le dysplastic nevus. O faʻailoga e mafai ona liua le dysplastic nevus i le melanoma e aofia ai asymmetry, tele suiga o le pigmenti, poʻo se lanu efuefu. O nei kanesa e masani ona tupu i le laʻititi o tausaga (e tusa ma le ogatotonu o le tolusefulu), e mafai ona tele, ma e masani ona i luga o le ogalaau. I le faʻataʻitaiga, dysplastic nevi o loʻo i le va o benign nevi ma melanoma. Ae peitaʻi, e naʻo le 20 % i le 30 % o melanomas e sau mai existing nevi. Talu ai o le tele o nevi e le avea ma melanoma, e masani lava e le fautuaina e aveese ma puipuia.
Dysplastic nevus, also called atypical or Clark nevus, can be precursor to melanoma, as the observation that 36% of melanomas have dysplastic nevi near the invasive tumor supports. Signs that a dysplastic nevus may have transitioned into a melanoma include asymmetry in contour, a noticeable increase in pigment variations, or a grayish tint indicating regression. These malignancies typically arise at a younger age (mid-thirties), are sometimes multiple, and are often found on the trunk. Molecularly, dysplastic nevi have a profile intermediate between benign nevi and malignant melanoma. While there is a recognized connection between dysplastic nevi and melanoma, it’s crucial to note that only about 20% to 30% of melanomas evolve from preexisting nevi. Given that the majority of dysplastic and typical nevi do not develop into melanoma, preventive removal of melanocytic nevi is not typically advised.
Malignant Melanoma 29262210 NIH
O le melanoma o se ituaiga tuma e tupu pe a avea melanocytes, sela e nafa ma le lanu o le paʻu, ma kanesa. Melanocytes e afua mai i le neural crest. O lona uiga e le gata e mafai ona tupu le melanoma i luga o le paʻu ae faapea foʻi i isi vaega o loʻo feoai ai sela o le neural crest, e pei o le gastrointestinal tract ma le faiʻai. O le fua faatatau o le ola mo tagata maʻi e maua i le amataga o le melanoma (laasaga 0) e maualuga i le 97%, ae e paʻū tele i le tusa ma le 10% mo i latou e maua i le tulaga maualuga (tuʻulaga IV).
A melanoma is a tumor produced by the malignant transformation of melanocytes. Melanocytes are derived from the neural crest; consequently, melanomas, although they usually occur on the skin, can arise in other locations where neural crest cells migrate, such as the gastrointestinal tract and brain. The five-year relative survival rate for patients with stage 0 melanoma is 97%, compared with about 10% for those with stage IV disease.
○ Aafiaga o le kanesa
E pei ona vaaia i tagata Caucasian i le Iunaite Setete, oi latou e maua i le dysplastic nevi e iai le lamatiaga i le olaga atoa e atiaʻe le melanoma e sili atu i le 10%. I le isi itu, oi latou e leai ni dysplastic nevus e iai le lamatiaga o le atiaʻe o le melanoma e itiiti ifo i le 1%.
○ Lapataiga mo tagata e maua i le dysplastic nevi
E masani ona fautuaina le su'esu'eina o le pa'u mo le puipuia o le melanoma (e ala i le iloa o atypical nevi e mafai ona aveese) po'o le vave iloa o tuma o iai. O tagata e iai se tala fa'asolopito o le tagata lava ia po'o le aiga o le kanesa o le pa'u po'o le tele o atypical nevi e tatau ona va'ai se foma'i foma'i ia le itiiti ifo ma le fa'atasi i le tausaga ina ia mautinoa latou te le o atia'e le melanoma.
O le fa'apu'upu'u [ABCDE] sa aoga mo le fesoasoani i le au tausi soifua maloloina ma tagata ta'ilalo e manatua uiga autu o le ma'i ma'i. Ae paga lea mo le tagata lautele, o le tele o seborrheic keratoses, o nisi lentigo senilis, ma e oo lava i warts atonu e iai uiga [ABCDE], ma e le mafai ona iloagofie mai le melanoma.
○ [ABCDE]
Asymmetrical: Manu'a pa'u e le tutusa.
Border: O le tuaoi o le manu'a e le masani.
Color: melanomas e masani ona tele lanu fa'aletonu.
Diameter: nevi e sili atu i le 6 mm e sili atu ona maua i le melanomas nai lo nevi laiti.
Evolution: O le evolusione (e pei o le suiga) o se nevus poʻo se faʻamaʻi e mafai ona faʻaalia ai ua amata ona leaga le melanoma.